Blue Horseshoe Stocks: NUGN Recap & More

NuGene International, Inc. NUGN

We came back to NUGN just in the nick of time yesterday, to start the week off on a high note. We identified the stock’s finding of support on Friday after a recent backslide, and pointed out the significance of yesterday’s PR. We postulated that the concurrence of those events could lead to a rebound on the chart, and  the stock followed our expectations to the letter.

From a low of 1.66, the it traded up to a high-of-day at 2.30; that’s an intraday pop of 39% We’ll be in the lookout for a protracted rebound out of NUGN as it attempts to regain the considerable amount of ground that it’s lost over the past month. We’ll want to see the stock maintain support at or above last Wednesday’s swing-low of 1.92 on any pullbacks in order for us to remain interested.


Pazoo, Inc. PZOO

Speaking of coming back to familiar stocks at an opportune time; we want to turn our attention back to PZOO this morning. In addition to releasing a PR containing information about the early success of wholly-owned subsidiary CannabisKing’s ‘Accuvape’ line (PR Below), the chart has reached a point where a rebound appears imminent.

As we’ve pointed out below, the stock has maintained what we’ve come to recognize as a base-level of support at .0045, and is beginning to show signs that yet another recovery is in the cards. Recent activity qualifies PZOO as a ‘Double Bottom’ (>>Investopedia Definition) which lends support to that conclusion. We’ll be watching the trading action in PZOO heavily this week as a result.

WHIPPANY, N.J., Aug. 18, 2015 /PRNewswire/ — Pazoo, Inc. (OTC Pinks: PZOO), is pleased to report that 100% wholly owned subsidiary CannabisKing Distribution, LLC, in just one week after training, completes multiple sales for the AccuVape product line in Nevada, Colorado, New Jersey and New York. After such an initial sales success, CannabisKing has lined up dozens of sales calls over the next few weeks, most from new client referrals.  CannabisKing is confident they will be able to introduce the AccuVape line to a larger market share, nationally. >>VIEW FULL PR


Tesla Motors, Inc. TSLA – Options Update

Yesterday we identified potential intraday and/or intraweek trading opportunities in TSLA Weekly $250-265 Calls. We’ll be monitoring that range consistently over the course of the week, and saw the first significant action yesterday in the $250 and $252.50’s:

$250 Calls – Range: 5.09-7.70 – Max Gain: 51%
$252.50 Calls – Range: 3.89-5.92 – Max Gain: 52%


Extended Watchlist:
OMER(Big-Gapper)